Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT01589679
Other study ID # DYN1-12-047
Secondary ID
Status Terminated
Phase N/A
First received April 30, 2012
Last updated August 8, 2013
Start date April 2012

Study information

Verified date August 2013
Source Dynasplint Systems, Inc.
Contact n/a
Is FDA regulated No
Health authority United States: Food and Drug Administration
Study type Interventional

Clinical Trial Summary

To determine the efficacy of Metatarsal Dynasplint Sytem (MTP) in reducing contracture of hallux limitus secondary to Bunionectomy, in a longitudinal, controlled trial.


Recruitment information / eligibility

Status Terminated
Enrollment 40
Est. completion date
Est. primary completion date May 2016
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 90 Years
Eligibility Inclusion Criteria:

- Diagnosis 1st MTJ Contracture following Bunionectomy

Exclusion Criteria:

- Current treatment with Botulinium Toxin-A (Botox), lower extremity

- Current treatment Fluoroquinolones (antibiotic medication)

- Current use of muscle relaxant medications

- Fibromyalgia

- Stroke, CVA, Brain Injury, Spinal Cord Injury, or any neural pathology causing plasticity or hypertonicity

- Treatment with electrical stimulation assisting ambulation (i.e Bioness, WalkAide, Parastep, etc.)

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Other:
standard of care
Dynamic Splinting utilizes the protocols of Low-Load, Prolonged-Duration Stretch (LLPS) with calibrated, adjustable tension to increase the Total End Range Time (TERT) to reduce contracture. This unit is work for 60 minutes three times per day.
Device:
Metarsal Dynasplint
Dynamic Splinting utilizes the protocols of Low-Load, Prolonged-Duration Stretch (LLPS) with calibrated, adjustable tension to increase the Total End Range Time (TERT) to reduce contracture. This unit is work for 60 minutes three times per day.

Locations

Country Name City State
United States Tufts Medical Center Boston Massachusetts
United States Brown Hand Center and Achilles Foot & Ankle Specialist Henderson Nevada
United States Advanced Diagnostic Foot and Ankle Specialist of Cy-Fair Houston Texas

Sponsors (1)

Lead Sponsor Collaborator
Dynasplint Systems, Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary A Repeated Measures Analysis of Variance (ANOVA) ANOVA will be performed to measure different in category, pain, duration to full restoration of active range of motion(AROM). 12 months No
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT05399472 - Teenage Functional Hallux Limitus and Ankle Dorsiflexion Study
Completed NCT03843177 - Association of Ingrown Toenails With Flat Foot, Hallux Abducto Valgus and Hallux Limitus
Completed NCT01048450 - Surgical Treatment for Hallux Rigidus N/A
Completed NCT00717691 - Hallux Limitus Treated With Dynamic Splinting: A Randomized, Controlled Trial N/A
Completed NCT04607863 - Foot Posture Index, Hallux Limitus in Patients With Chronic Low Back Pain. Gait With Optogait Sensor
Recruiting NCT05511532 - Foot Orthoses & Hallux Limitus in School-age Children N/A
Completed NCT01284985 - Short Term Follow-up of Patient Implanted With the Metatarso-Phalangeal Prosthesis METIS® N/A